Search Results - "Niess, H"

Refine Results
  1. 1

    Age and metastasis – How age influences metastatic spread in cancer. Colorectal cancer as a model by Pretzsch, E., Nieß, H., Bösch, F., Westphalen, C.B., Jacob, S., Neumann, J., Werner, J., Heinemann, V., Angele, M.K.

    Published in Cancer epidemiology (01-04-2022)
    “…Metastasis is the major cause of death in cancer patients. Whereas colorectal cancer (CRC) incidence increases with age, metastatic spread seems to decline…”
    Get full text
    Journal Article
  2. 2

    Treatment of pancreatic injuries after blunt abdominal trauma by Nieß, H, Werner, J

    Published in Chirurgie (Heidelberg, Germany) (01-08-2023)
    “…Pancreatic injuries resulting from blunt abdominal trauma are uncommon but carry a high risk of morbidity and mortality for patients. Prompt diagnosis and…”
    Get more information
    Journal Article
  3. 3

    Effect of platelet inhibition with perioperative aspirin on survival in patients undergoing curative resection for pancreatic cancer: a propensity score matched analysis by Pretzsch, E, D'Haese, J G, Renz, B, Ilmer, M, Schiergens, T, Miksch, R C, Albertsmeier, M, Guba, M, Angele, M K, Werner, J, Nieß, H

    Published in BMC surgery (22-02-2021)
    “…The importance of platelets in the pathogenesis of metastasis formation is increasingly recognized. Although evidence from epidemiologic studies suggests…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Preservation of the round ligament to accommodate transient portal hypertension after major hepatectomy by Koliogiannis, D., Nieß, H., Koliogiannis, V., Ilmer, M., Angele, M., Werner, J., Guba, M.

    Published in Langenbeck's archives of surgery (01-09-2022)
    “…Purpose Posthepatectomy liver failure (PHLF) remains a leading cause of death after extensive liver resection. Apart from the size and function of the…”
    Get full text
    Journal Article
  6. 6

    In-vitro model to mimic T cell subset change in human PDAC organoid co-culture by Knoblauch, M., Ma, T., Beirith, I., Koch, D., Hofmann, F., Heinrich, K., Aghamaliev, U., Sirtl, S., Westphalen, C. B., Nieß, H., Reichert, M., Angele, M. K., Regel, I., Bazhin, A. V., Werner, J., Ilmer, M., Renz, Bernhard W.

    “…Purpose Immunotherapies have largely failed as treatment options for pancreatic ductal adenocarcinoma (PDAC). In this field, clinical translational studies…”
    Get full text
    Journal Article
  7. 7

    Influence of Klebsiella pneumoniae and quinolone treatment on prognosis in patients with pancreatic cancer by Weniger, M, Hank, T, Qadan, M, Ciprani, D, Michelakos, T, Niess, H, Heiliger, C, Ilmer, M, D'Haese, J G, Ferrone, C R, Warshaw, A L, Lillemoe, K D, Werner, J, Liss, A, Fernández-Del Castillo, C

    Published in British journal of surgery (22-06-2021)
    “…An increasing body of evidence suggests that microbiota may promote progression of pancreatic ductal adenocarcinoma (PDAC). It was hypothesized that…”
    Get full text
    Journal Article
  8. 8

    Obesity in Humans Is Characterized by Gut Inflammation as Shown by Pro-Inflammatory Intestinal Macrophage Accumulation by Rohm, Theresa V., Fuchs, Regula, Müller, Rahel L., Keller, Lena, Baumann, Zora, Bosch, Angela J. T., Schneider, Romano, Labes, Danny, Langer, Igor, Pilz, Julia B., Niess, Jan H., Delko, Tarik, Hruz, Petr, Cavelti-Weder, Claudia

    Published in Frontiers in immunology (12-05-2021)
    “…Chronic low-grade inflammation is a hallmark of obesity and associated with cardiovascular complications. However, it remains unclear where this inflammation…”
    Get full text
    Journal Article
  9. 9

    Inhibition of the mammalian target of rapamycin impedes lymphangiogenesis by Huber, S., Bruns, C.J., Schmid, G., Hermann, P.C., Conrad, C., Niess, H., Huss, R., Graeb, C., Jauch, K.-W., Heeschen, C., Guba, M.

    Published in Kidney international (01-04-2007)
    “…Lymphatic complications are common side effects of mammalian target of rapamycin (mTOR) inhibitor-based immunosuppression in kidney transplantation. Therefore,…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Low Discontinuation Rate of Infliximab Treatment in Steroid-Dependent/Refractory Crohn’s Disease Patients by Kaymak, Tanay, Moriconi, Federico, Niess, Jan H., Beglinger, Christoph, Hruz, Petr

    Published in Inflammatory intestinal diseases (01-03-2018)
    “…Background: Many patients with moderate to severe Crohn’s disease (CD) are treated with infliximab (IFX). As most of these patients experience a long-lasting…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Recombinant TIMP-1-GPI inhibits growth of fibrosarcoma and enhances tumor sensitivity to doxorubicin by Bao, Q., Niess, H., Djafarzadeh, R., Zhao, Y., Schwarz, B., Angele, M. K., Jauch, K.-W., Nelson, P. J., Bruns, C. J.

    Published in Targeted oncology (01-09-2014)
    “…Fibrosarcomas show a high incidence of recurrence and general resistance to apoptosis. Limiting tumor regrowth and increasing their sensitivity to chemotherapy…”
    Get full text
    Journal Article
  14. 14

    Significance of Mesenchymal Stem Cells in Gastrointestinal Disorders by Gamba, S, Zhao, Y, Zhao, L, Wang, Y, Schwarz, B, Primo, S, Jauch, K-W, Nelson, P J, Modest, D P, Nieß, H, Bruns, C

    Published in Zentralblatt fur Chirurgie (01-06-2015)
    “…In this review we summarise the recent developments regarding the experimental and clinical use of mesenchymal stem cells (MSCs), focusing mainly on the…”
    Get more information
    Journal Article
  15. 15
  16. 16

    Zystische Pankreastumoren by Nieß, H., Mayerle, J., D’Anastasi, M., Werner, J.

    Published in Der Onkologe (01-02-2017)
    “…Zusammenfassung Der Begriff zystischer Pankreastumor umfasst heterogene Erkrankungen neoplastischen oder nichtneoplastischen Ursprungs, die sich in Bezug auf…”
    Get full text
    Journal Article
  17. 17

    Clinical implication of targeting of cancer stem cells by Zhao, L, Zhao, Y, Bao, Q, Niess, H, Jauch, K-W, Bruns, C J

    Published in European surgical research (01-01-2012)
    “…The existence of cancer stem cells (CSCs) is receiving increasing interest particularly due to its potential ability to enter clinical routine. Rapid advances…”
    Get more information
    Journal Article
  18. 18

    CX(3)CR1(+) macrophages support IL-22 production by innate lymphoid cells during infection with Citrobacter rodentium by Manta, C, Heupel, E, Radulovic, K, Rossini, V, Garbi, N, Riedel, C U, Niess, J H

    Published in Mucosal immunology (01-01-2013)
    “…Innate immune cells, such as intestinal epithelial cells, dendritic cells (DCs), macrophages, granulocytes, and innate lymphoid cells provide a first line of…”
    Get full text
    Journal Article
  19. 19

    CX3CR1+ macrophages support IL-22 production by innate lymphoid cells during infection with Citrobacter rodentium by Manta, C, Heupel, E, Radulovic, K, Rossini, V, Garbi, N, Riedel, C U, Niess, J H

    Published in Mucosal immunology (2013)
    “…Innate immune cells, such as intestinal epithelial cells, dendritic cells (DCs), macrophages, granulocytes, and innate lymphoid cells provide a first line of…”
    Get full text
    Journal Article
  20. 20